Drugs in ATC Class C08CA

✉ Email this page to a colleague

« Back to Dashboard

Up to Top Level ATC Classes

Up to C - Cardiovascular system

Up to C08 - CALCIUM CHANNEL BLOCKERS

Up to C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS

Drugs in ATC Class: C08CA - Dihydropyridine derivatives drug patent expirations, market exclusivity, and generic launch dates

Glossary

Subscribe to access the full database, or Subscribe
Tradename	Generic Name
TEKAMLO	aliskiren hemifumarate; amlodipine besylate
AMTURNIDE	aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide
AMLODIPINE BENZOATE	amlodipine benzoate
KATERZIA	amlodipine benzoate
NORLIQVA	amlodipine besylate
AMLODIPINE BESYLATE	amlodipine besylate
>Tradename	>Generic Name

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.